Tradestie Institutional Equity Comparison Engine

PACB vs ECOR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ECOR Overall Edge

ECOR Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to electroCore, Inc. Common Stock (ECOR) driven by superior Growth & Margin, Options & Structure while PACB counters with relative strength in Momentum & Technical. Fundamentally, PACB trades at N/M Forward P/E with -333.0% operating margin (+5.5% YoY revenue) versus ECOR at N/M Forward P/E and -33.1% operating margin (+11.5% YoY). In options structure, PACB sits in BREAKDOWN (97th %ile IV; Dealer Gamma Walls on Pro) against ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
PACB N/M vs ECOR N/M Fwd P/E
Growth & Margin Winner ECOR
Op Margin -333.0% vs -33.1% ยท YoY +5.5% vs +11.5%
Momentum & Technical Winner PACB
1Y +6.7% vs -4.0% ยท 52W Pos 29% vs 6%
Options & Structure Winner ECOR
BREAKDOWN (97th %ile IV) vs UNCLASSIFIED (N/A IV)
PACB NASDAQ
Pacific Biosciences of California, Inc.
Laboratory Analytical Instruments
$1.76
-3.83% 1D
Market Cap $571.4M
1M Return -17.76%
1Y Return +6.67%
Forward P/E N/M
Unified AI Score
60.0 / 100 BUY
Tech 59.0 Fund 52.0 Flow 57.0 Mom 60.0
ECOR NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.85
-6.19% 1D
Market Cap $47.7M
1M Return -34.01%
1Y Return -3.96%
Forward P/E N/M
Unified AI Score
56.8 / 100 HOLD
Tech 68.0 Fund 53.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PACB +6.67% ECOR -3.96% Spread: +10.63 pp (PACB Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PACB Revenue ECOR Revenue PACB Op. Margin ECOR Op. Margin Margin Edge
FY2018 $80M $0M -128.4% -5494.1% PACB
FY2019 $90M $0M -110.6% -1928.2% PACB
FY2020 $80M $0M -132.3% -707.9% PACB
FY2021 $130M $10M -161.2% -367.7% PACB
FY2022 $130M $10M -239.4% -266.2% PACB
FY2023 $200M $20M -166.8% -120.2% ECOR
FY2024 $150M $30M -308.0% -48.3% ECOR
FY2025 $160M $30M -346.2% -41.1% ECOR

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PACB (4) vs ECOR (4)
Institutional Metric PACB ECOR Criterion Row Winner
Market Capitalization Scale $571.4M $47.7M Larger Scale PACB
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +5.5% +11.5% Higher Growth ECOR
Operating Margin (TTM) Profitability -333.0% -33.1% Higher Margin ECOR
Net Profit Margin Profitability -81.3% -33.5% Higher Margin ECOR
Return on Equity (ROE) Capital Efficiency -929.3% -478.7% Higher ROE ECOR
52-Week Range Position Momentum 29% ($1โ€“$3) 6% ($4โ€“$13) Stronger Trend PACB
Beta / 30D Volatility Risk Regime 2.27ฮฒ ยท 103% Vol 1.52ฮฒ ยท 155% Vol Lower Realized Risk PACB
Unified Institutional Score Composite Signal 60.0 / 100 (BUY) 56.8 / 100 (HOLD) Higher Composite PACB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PACB vs ECOR Buy Guide
PACB BREAKDOWN
15d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 97th %ile
IV Regime Extreme (>80th %ile)
Live PACB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ECOR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ECOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PACB nor ECOR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.